Soterix Medical (SMI) is a company focusing on neuropsychiatric and neurological disorders and rehabilitation. It specializes in clinical trials for non-invasive neuromodulation and integrated brain monitoring technology. The company offers high-definition transcranial direct current stimulation (HD-tDCS), limited total energy tDCS (LTE-tDCS), and neurotargeting.